ARCHIVES

NCI selects nanotech centers for funding.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Plans To Expand CTSU Management Of Clinical Trials.

February 24, 2006

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

CCIRC Holds Groups To 1980 Spending Levels, But They May Get Even Less

January 9, 1981

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

“Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.”

July 14, 1995